Liver Cancer Trial, Recruiting NCT06944483 Sponsor: Seoul National University Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06944483
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by biopsy and/or imaging scans
  • Your liver tumor is 5 centimeters or larger
  • The abnormal blood vessels inside your tumor are 3 millimeters or smaller in size
  • Your liver function falls into a category called "Child-Pugh class A," meaning your liver is functioning relatively well (confirm with trial site)
  • You are either fully active or able to carry out light work daily (based on a standard activity scale called ECOG 0 or 1)
  • Your blood test results meet specific requirements, including acceptable levels of white blood cells, red blood cells, platelets, liver enzymes, bilirubin, a blood clotting measure (INR), and kidney function (the trial team will check these)
  • You are expected to live for more than 3 months
  • You have read and signed a consent form showing you understand and agree to take part in the trial
  • If you are a woman who could become pregnant, you must currently not be pregnant

Who may not be able to join:

  • Your liver cancer has spread into the hepatic veins (blood vessels leaving the liver), as seen on a CT or MRI scan
  • There are signs of significant blood vessel involvement in the portal vein or hepatic vein on certain imaging scans
  • You have had a procedure called TIPS (a shunt placed inside the liver to redirect blood flow)
  • The abnormal blood vessels inside your tumor are larger than 3 millimeters
  • Your liver cancer has spread into the main portal vein (the large blood vessel supplying the liver)
  • You have a serious lung condition such as severe COPD or significant scarring of the lungs
  • You have a biliary stent (a tube placed in your bile ducts) or a surgical connection between your bile ducts and intestine

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 82-10-5136-5205

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 April 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

percentage of execution of same-day radioembolization procedure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov